Progression-Free Survival in Patients Receiving Chemotherapy Alone (C) or Chemotherapy with Bevacizumab (CB) for First-Line Treatment of KRAS Mutant Metastatic Colorectal Cancer in Community Oncology Settings

Arthur C. Houts, Sarika Ogale, Yousuf Zafar, Joleen M Hubbard, Sacha Satram-Hoang, Nicolas Sommer, Mark S. Walker

Research output: Contribution to journalArticle

1 Scopus citations

Fingerprint Dive into the research topics of 'Progression-Free Survival in Patients Receiving Chemotherapy Alone (C) or Chemotherapy with Bevacizumab (CB) for First-Line Treatment of KRAS Mutant Metastatic Colorectal Cancer in Community Oncology Settings'. Together they form a unique fingerprint.

Medicine & Life Sciences